MYCELX Technologies Corporation Net Assets

Latest as of June 2026: GBX4.25 Million GBX ≈ $517.59 USD

MYCELX Technologies Corporation net assets. Based on the latest financial reports, MYCELX Technologies Corporation (MYX) has net assets worth GBX4.25 Million GBX (≈ $517.59 USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX8.77 Million ≈ $1.07K USD) and total liabilities (GBX4.52 Million ≈ $549.71 USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore MYCELX Technologies Corporation net asset momentum to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	GBX4.25 Million
% of Total Assets	48.5%
Annual Growth Rate	15.62%
5-Year Change	-55.17%
10-Year Change	-69.96%
Growth Volatility	337.43

Net Assets of MYCELX Technologies Corporation (2008–2025)

Net assets of MYCELX Technologies Corporation from 2008 to 2025. This chart illustrates how MYCELX Technologies Corporation's net assets have evolved over time, based on quarterly financial data. See MYCELX Technologies Corporation balance sheet independence to measure how much of total assets are equity-financed.

Annual Net Assets for MYCELX Technologies Corporation (2008–2025)

The table below shows the annual net assets of MYCELX Technologies Corporation from 2008 to 2025. For live market cap and overall valuation, see MYX company net worth.

Year	Net Assets	Change
2025-12-31	GBX5.66 Million ≈ $688.54	+7.52%
2024-12-31	GBX5.26 Million ≈ $640.35	-26.46%
2023-12-31	GBX7.16 Million ≈ $870.80	-33.93%
2022-12-31	GBX10.83 Million ≈ $1.32K	-14.18%
2021-12-31	GBX12.62 Million ≈ $1.54K	-8.48%
2020-12-31	GBX13.79 Million ≈ $1.68K	-30.50%
2019-12-31	GBX19.84 Million ≈ $2.41K	-5.38%
2018-12-31	GBX20.97 Million ≈ $2.55K	+17.73%
2017-12-31	GBX17.82 Million ≈ $2.17K	-5.45%
2016-12-31	GBX18.84 Million ≈ $2.29K	-14.35%
2015-12-31	GBX22.00 Million ≈ $2.68K	-12.10%
2014-12-31	GBX25.02 Million ≈ $3.04K	+31.37%
2013-12-31	GBX19.05 Million ≈ $2.32K	+15.77%
2012-12-31	GBX16.45 Million ≈ $2.00K	-6.39%
2011-12-31	GBX17.58 Million ≈ $2.14K	+1431.41%
2010-12-31	GBX1.15 Million ≈ $139.64	+41.67%
2009-12-31	GBX810.07K ≈ $98.56	+68.85%
2008-12-31	GBX479.75K ≈ $58.37	--

Equity Component Analysis

This analysis shows how different components contribute to MYCELX Technologies Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 3515570660.0% over the analyzed period, potentially due to dividend distributions or operating losses.

MYCELX Technologies Corporation Net Assets Breakdown (December 2025)

MYCELX Technologies Corporation net assets breakdown by equity component as of December 2025.

Component	Amount	Percentage
Common Stock	GBX609.00K	10.76%
Other Components	GBX45.66 Million	806.77%
Total Equity	GBX5.66 Million	100.00%

MYCELX Technologies Corporation Competitors by Market Cap

The table below lists competitors of MYCELX Technologies Corporation ranked by their market capitalization.

Company	Market Cap
Power Metal Resources plc LSE:POW	$138.30K
Akoustis Technologies, Inc. NASDAQ:AKTSQ	$138.60K
DSW Capital PLC LSE:DSW	$139.13K
Croma Security Solutions Group Plc LSE:CSSG	$139.88K
Mosman Oil and Gas Ltd LSE:MSMN	$136.82K
Ondo InsurTech PLC LSE:ONDO	$135.80K
Cerinnov Group SA PA:ALPCV	$134.84K
LORDS CO. WORLDW. HOLD. F:4XM	$134.78K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in MYCELX Technologies Corporation's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 5,263,000 to 5,659,000, a change of 396,000 (7.5%).
Net income of 334,000 contributed positively to equity growth.
Other factors increased equity by 62,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	GBX334.00K	+5.9%
Other Changes	GBX62.00K	+1.1%
Total Change	GBX-	7.52%

Book Value vs Market Value Analysis

This analysis compares MYCELX Technologies Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 212.14x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 1252.58x to 212.14x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2008-12-31	GBX0.04	GBX46.50	x
2009-12-31	GBX0.06	GBX46.50	x
2010-12-31	GBX0.09	GBX46.50	x
2011-12-31	GBX1.92	GBX46.50	x
2012-12-31	GBX1.27	GBX46.50	x
2013-12-31	GBX1.33	GBX46.50	x
2014-12-31	GBX1.84	GBX46.50	x
2015-12-31	GBX1.18	GBX46.50	x
2016-12-31	GBX1.00	GBX46.50	x
2017-12-31	GBX0.95	GBX46.50	x
2018-12-31	GBX1.05	GBX46.50	x
2019-12-31	GBX1.03	GBX46.50	x
2020-12-31	GBX0.71	GBX46.50	x
2021-12-31	GBX0.65	GBX46.50	x
2022-12-31	GBX0.49	GBX46.50	x
2023-12-31	GBX0.31	GBX46.50	x
2024-12-31	GBX0.22	GBX46.50	x
2025-12-31	GBX0.22	GBX46.50	x

Capital Efficiency Dashboard

This dashboard shows how efficiently MYCELX Technologies Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 5.90%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 2.84%
• Asset Turnover: 1.35x
• Equity Multiplier: 1.53x
Recent ROE (5.90%) is above the historical average (-8.58%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2008	72.95%	13.09%	1.93x	2.88x	GBX301.99K
2009	22.16%	7.00%	1.80x	1.76x	GBX98.47K
2010	29.60%	7.90%	1.93x	1.94x	GBX224.99K
2011	-15.72%	-44.16%	0.33x	1.09x	GBX-4.52 Million
2012	-12.01%	-16.07%	0.63x	1.18x	GBX-3.62 Million
2013	2.97%	2.64%	0.77x	1.45x	GBX-1.34 Million
2014	-23.66%	-43.59%	0.41x	1.33x	GBX-8.42 Million
2015	-16.59%	-26.85%	0.54x	1.15x	GBX-5.85 Million
2016	-17.40%	-41.39%	0.35x	1.19x	GBX-5.16 Million
2017	-6.50%	-8.42%	0.64x	1.21x	GBX-2.94 Million
2018	14.64%	11.39%	0.96x	1.33x	GBX972.70K
2019	-14.91%	-24.85%	0.49x	1.23x	GBX-4.94 Million
2020	-44.19%	-85.78%	0.37x	1.39x	GBX-7.47 Million
2021	-11.29%	-16.81%	0.54x	1.24x	GBX-2.69 Million
2022	-36.84%	-39.81%	0.74x	1.26x	GBX-5.07 Million
2023	-51.78%	-33.98%	1.05x	1.45x	GBX-4.42 Million
2024	-51.74%	-55.54%	0.49x	1.91x	GBX-3.25 Million
2025	5.90%	2.84%	1.35x	1.53x	GBX-231.90K

Industry Comparison

This section compares MYCELX Technologies Corporation's net assets metrics with peer companies in the Pollution & Treatment Controls industry.

Industry Context

Industry: Pollution & Treatment Controls
Average net assets among peers: $41,184,000
Average return on equity (ROE) among peers: 6.97%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
MYCELX Technologies Corporation (MYX)	GBX4.25 Million	72.95%	1.06x	$137.84K
Porvair plc (PRV)	$41.18 Million	6.97%	0.80x	$4.92 Million

About MYCELX Technologies Corporation

LSE:MYX UK Pollution & Treatment Controls

Market Cap

$137.84K

GBX1.13 Billion GBX

Market Cap Rank

#31442 Global

#1063 in UK

Share Price

GBX46.50

Change (1 day)

+0.00%

52-Week Range

GBX25.50 - GBX66.50

All Time High

GBX270.00